Venture • Life Science

NorthSpring Capital Partners Invests In Mesosil

On July 13, 2021, growth capital firm NorthSpring Capital Partners invested in life science company Mesosil

Investment Context
  • This is NorthSpring Capital Partners’ 1st transaction in the Life Science sector.
  • This is NorthSpring Capital Partners’ 13th transaction in Canada.
  • This is NorthSpring Capital Partners’ 13th transaction in Ontario.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date July 13, 2021
Target Mesosil
Sector Life Science
Investor(s) NorthSpring Capital Partners
Deal Type Venture

Target Company

Mesosil

Toronto, Ontario, Canada
Mesosil is developing the lifetime-effect antimicrobial materials for dental and medical devices. Mesosil was founded in 2018 and is based in Toronto, Ontario.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

NorthSpring Capital Partners

Cambridge, Ontario, Canada

Investor Investor Investor Investor


Category Growth Capital Firm
Founded 2009
Size Small
Type Sector Agnostic
DESCRIPTION

NorthSpring Capital Partners is a provider of subordinated debt and equity capital to small businesses. The Firm takes minority positions and looks to invest $250k to $1 million to support management buyouts, acquisitions, growth needs, and in select special situations. NorthSpring generally targets 'local' business within a short drive of its office and will consider investing in a variety of industries including manufacturing, distribution and wholesale, business services, and technology. NorthSpring was formed in 2009 and is based in Cambridge, Ontario.


Deal Context for Investor #
Overall 13 of 15
Sector: Life Science 1 of 1
Type: Venture 5 of 7
State: Ontario 13 of 14
Country: Canada 13 of 15
Year: 2021 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-23 FluidAI

Kitchener, Ontario, Canada

NERv aims to create a paradigm shift in post-operative care, utilizing the plethora of data within the body, to help in the detection of post-operative complications at their onset. NERv’s platform sensing technology augments existing wound drains and catheters, providing healthcare providers with a smart monitoring tool that can enhance the delivery of care. FluidAI was founded in 2014 and is based in Kitchener, Ontario.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-14 ComTech Energy

Milton, Ontario, Canada

ComTech Energy designs/build/maintains CNG fuelling infrastructure across Canada and has an in-house team of engineers, project managers, gas fitters, electricians and certified service technicians whose primary focus is customer satisfaction. ComTech Energy was founded in 2009 and is based in Milton, Ontario.

Sell -

Explore Related M&A Activity